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Abstract In previous works we reported the design,
synthesis and in vitro evaluations of synthetic anionic
polymers modified by alicyclic pendant groups (hydro-
phobic anchors), as a novel class of inhibitors of the human
immunodeficiency virus type 1 (HIV-1) entry into human
cells. Recently, these synthetic polymers interactions with
key mediator of HIV-1 entry-fusion, the tri-helix core of
the first heptad repeat regions [HR1]3 of viral envelope
protein gp41, were pre-studied via docking in terms of
newly formulated algorithm for stepwise approximation
from fragments of polymeric backbone and side-group
models toward real polymeric chains. In the present article
the docking results were verified under molecular dynam-
ics (MD) modeling. In contrast with limited capabilities of
the docking, the MD allowed of using much more large
models of the polymeric ligands, considering flexibility of
both ligand and target simultaneously. Among the syn-
thesized polymers the dinorbornen anchors containing
alternating copolymers of maleic acid were selected as the
most representative ligands (possessing the top anti-HIV
activity in vitro in correlation with the highest binding
energy in the docking). To verify the probability of binding
of the polymers with the [HR1]3 in the sites defined via
docking, various starting positions of polymer chains were
tried. The MD simulations confirmed the main docking-
predicted priority for binding sites, and possibilities for
axial and belting modes of the ligands–target interactions.
Some newly MD-discovered aspects of the ligand’s back-
bone and anchor units dynamic cooperation in binding the
viral target clarify mechanisms of the synthetic polymers
anti-HIV activity and drug resistance prevention.
Keywords Molecular dynamics  Docking  Polymer–
biopolymer interaction  Drug design  Maleic acid
copolymer  Norbornane/tetracyclododecen derivatives 
HIV entry (fusion) inhibitor  Glycoprotein gp41
Introduction
A complementary development of docking and molecular
dynamics (MD) techniques in application to a computer-
aided modeling of specific interactions between synthetic
and biological polymers is very promising platform for
novel advancements in modern medicine, biotechnology
and pharmacy. Particularly, in antiviral drug design area,
the computational modeling of synthetic polymers inter-
ference with glycoprotein gp41 mediators of the human
immunodeficiency virus type 1 (HIV-1) entry into human
cells may open new prospects toward preventive anti-HIV
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inhibitors. Such drugs are vitally needed for modern anti-
HIV/AIDS1 prophylaxis and therapy [1, 2].
In previous works we reported the design, synthesis and
in vitro2 evaluations of the novel series of anti-HIV
inhibitors based on synthetic anionic polymers modified by
alicyclic pendant groups (hydrophobic anchors) through
the variable spacers (bridges) [3–8]. Within this series of
polymers the alternating cyclocopolymers of divinyl ether
with maleic acid/their salt (see Scheme 1, formula I) pos-
sess the amplified anti-HIV activity [9], when the side
groups (X = OH/ONa) are partially (optimally, the 6–8 %
of total amount of the X-groups) substituted by the cage-
type anchors (Anc).
It was found that these polymeric compounds affect the
earliest stage of the HIV-1 entry. Partially retarding the
HIV-1 virions adsorption on cell membrane, they were able
to block the next (post-adsorption) step, fully preventing
the virus penetration through cell membrane toward cyto-
plasm and nucleus [3, 7]. Therefore, reviewing [7–10] the
HIV-1 entry, we concentrated upon the post-adsorption
event, namely, the fusion. It is well known [11–15] that the
fusion is driven by the HIV-1 envelope glycoprotein gp41.
Within the gp41 our attention was focused on the gp41
ectodomain first heptad repeat region (HR1), the amino
acid sequence Arg542–Leu581. Three molecular self-
assembly of these regions results in the three-helix com-
plex (3 HR1 ? [HR1]3), the key intermediate of the HIV-
1 envelope fusion with a permissive cell membrane
(Fig. 1).
The polymers of formula I we originally predicted and
designed for therapeutic intervention against the [HR1]3
complex, as potentially most sensitive target in the view of
both electrostatic and hydrophobic selectivity criteria [7].
The [HR1]3 possesses the combination of positively charged
and hydrophobic sites that, in theory, should be attractive for
the synthetic polymers (Scheme 1) complementarity
through anions (An) and anchors (Anc) simultaneously.
Therefore, just the [HR1]3 we taken into consideration as the
most probable target for the polymers I attack.
Then this assumption has been supported by results of a
computer-aided modeling the interactions between these
polymeric compounds and the viral biopolymer target via
the docking. The docking was performed recently in terms
of newly formulated algorithm for step-by-step approxi-
mation from fragments of polymeric backbone and side-
groups toward real polymeric chains [9, 16]. Among sub-
domains of the gp41 ectodomain (Fig. 1) the [HR1]3
complex was identified exactly as the target capable of
powerful binding with the models of formula I synthetic
polymers. And the binding energies of variable side-groups
(X) combinations were in good correlation with the in vitro
experimental data [9, 16].
Within the [HR1]3 3D structure (Fig. 2) the triplets of
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Scheme 1 The observable synthetic polymers. An—Anionic side
groups; Anc—pendant anchors derived from hydrophobic alicycles:
adamantane (Ad), norbornane (Nb), norbornen (Nb=),
epoxynorbornane (NbO), dinobornene (dNb)—i.e., tetracyclo-
[4.4.0.12.517.10]-dodecene, etc.; Y—spacer/bridge fragment linked
the Anc with polymeric backbone chain
Fig. 1 HIV-1 entry. Adsorption of HIV-1 virion on a permissive
cellular membrane (with CD4 and CCR5/CXCR4 receptors) exposing
the three gp41 molecules. Their hydrophobic N-terminus (FP)3 are
anchored in lipid matrix of cell membrane, while the C-tails (3 TM)
are bounded in the virus envelope. Ectodomains between the FP and
TM came into self-aggregation, forming tri-helix cationic
intermediate (3 HR1 ? [HR1]3) that becomes a core for consecutive
hairpin-like folding with three helices of contra-charged (anionic)
second heptad repeat regions (3 HR2). The resulted collapsing leads
to the fusion, which can be prevented via therapeutic blocking the
[HR1]3 core against contacts with the HR2 helixes [11–15]
1 AIDS—acquired immunodeficiency syndrome, the disease caused
by the HIV infection.
2 on experimental models of various HIV-1 strains infecting cells.
648 J Comput Aided Mol Des (2014) 28:647–673
123
observed around the target at least on the three levels: L1
(Gln567–Arg579), L2 (Leu556–Leu565) and L3 (Val549–
Asn553). Altogether there were nine hollows which could
provide stable contacts with ligands. All these cavities were
identified by the docking as zones of intensive binding the
polymers’ units from both anionic backbone3 and hydro-
phobic anchors insertable into the cavities. The L1 pockets,
being the deepest cavities, were the most powerful binding
locus for majority of the docking-tested models of the
polymer I motives [9, 16]. Similar findings were reported
by many other drug design investigators focused a docking-
based computer-aided screening the HIV-1 fusion inhibi-
tors within the L1 pockets [17–22]. Such focusing only to
the L1 triplet of pockets without any consideration of
additional capacities of the L2 and L3 triplets of cavities
could be acceptable just in case of small molecule ligands.
The size of small molecules (typically B1 nm) cannot
cover simultaneously more than one cavity/pocket on the
one from among L1/L2/L3 levels, where the L1 is prefer-
able in the ligand-binding competition with the L2/L3.
However, as soon as we deal with the polymeric com-
pounds, the mentioned situation is converted cardinally: the
polymeric chain of extended length (comparable with the
nano-scale of the biopolymeric target) provides the exten-
ded possibilities for simultaneous multipoint contacts with
more than one, several or full-scale binding vacancies on
the target’s surface. Just such tendency to polyvalent
binding has been discovered by the docking pre-study of
the polymers I in connection with the [HR1]3 complex [9,
16].
It was found [9, 16] that, depending on the degree of
polymerization (n), absence/presence of hydrophobic
anchors (among the side-groups X) and distances between
these anchors, the models of formula I (Scheme 1) were
capable of binding the [HR1]3 by different modes (Fig. 3).
The first mode (A) is an axial connection of the ligand
chains along the viral target helixes. The alternative mode
(B) is belting the target (due to the anchors contacts with
hydrophobic cavities within one level, predominantly, the
L1. The third mode (AB) represents an integrative
Fig. 2 3D organization of the
[HR1]3 complex, a target for the
anti-HIV-1 fusion intervention.
a Scheme of amino acid
sequences and resulted excesses
of electric charge for both HR1
and HR2 (at right the
connection between the three
HR2 and three HR1 coiled-coil
core is shown in view from
C-tail for the HRI a-helixes
repeat heptad motifs order: … a,
b, c, d, e, f, g…). b, c The
[HR1]3 core model, simulated
from 1AIK database and
displayed in ribbon and depth-
gradation forms, respectively. In
the ribbon the basic amino acids
are labeled by 1. In c three
levels (the L1, L2, and L3) of
cavity triplets (where every
cavity repeats itself three times
between adjacent a-helices on
the every level) are represented.
Amino acids surrounding one
among triplet of deepest cavities
(so-called ‘‘pockets’’) within L1
are shown in detail. The L1
pocket and smaller cavities of
L2/L3 areas are outlined with a
dotted curve
3 The binding selectively driven by counter-ionisable (cationic)
Lys574/Arg579 at L1, His564 at L2, and Arg567 at L3, respectively.
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combined axial-co-belting binding the target by full-scale
polymeric chains (in theoretical extrapolation toward the
real anti-HIV active polymeric compounds of formula I in
Scheme 1, where the degree of polymerization is n C 30
with content of anchors C9, i.e., the 6–8 % among the
X-groups).
Thus the computer-aided modeling of polymers I–
[HR1]3 interactions via docking
4 leaded to very useful
preliminary information, clarifying probable molecular
mechanisms of the synthetic polymers intervention in HIV-
1 entry (fusion). From the other hand, the docking proce-
dure have some fundamental limitations: (1) the docking is
limited by size of ligand models and directly can be applied
exclusively for relatively short fragments of the real
polymeric chains; (2) it takes into account conformational
flexibility of ligands only, while the target is considered in
general as a crystal-like rigid structure.5 All these restric-
tions can be overcome by MD.
Briefly resuming the docking results, in the current
article we consider the MD-based verification of the main
docking-predicted binding sites/modes of interactions
between the viral target and synthetic polymers of formula
I. The obtained from MD results are compared with the
docking ones. In addition, new light on peculiarities of
dynamic interactions between the synthetic and biological
polymers is discussed in prospect for novel drug design
development.
Experimental
The suggested methodology for stepwise docking, applied
early to pre-studying the considered polymeric objects, was
Fig. 3 Three-step docking-based modeling the polymers I–[HR1]3
interactions, the main results [9, 16]. Step 1 Small molecule size
models of the polymer’s fragments, e.g. (1), bind the target within the
three levels (L1–L3) of triplet cavities around target, preferably the
deepest pockets at the L1, where the models of Anc possess maximal
binding energies |-15.1| to |-18.7| kcal/mol (the dNb is the most
active Anc). Step 2 oligomeric models of the polymeric chain motifs
provides more effective binding with capacity of both axial and
belting orientation, depending on absence (2) or presence (3–4) of
active Anc and distances between the Anc along the polymeric chain.
Step 3 An extrapolation of the steps 1–2 results toward the real size of
polymers I chains, predicting possibility for significant combined
binding, DGbind C |-200| kcal/mol
4 Using the recently suggested algorithm, adapted for the polymer–
biopolymer interactions modelling [16].
5 The required simulation of flexibility is possible but within the
target’s local parts only.
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described in our previous reports [9, 16] in details. The
same viral target model, based on 1AIK PDB [23] in
application to the trimeric complex [HR1]3, was used for
the MD simulation as the starting target’s 3D-conforma-
tion. This model consists of triplet of the 36 amino acid a-
helixes (within the HR1 repeat heptad motifs) self-assem-
bled in the coiled-coil represented in Fig. 2.
The models for analyzed synthetic polymers (of the
formula I) were built by means of SYBYL 8.0 molecu-
lar graphics software package (Tripos Inc., St. Louis,
USA). In view of the big size of polymeric models, partial
charges on their atoms were determined by the Gasteiger-
Hu¨ckel method [24]. The MD simulations were performed
by using a suite of programs Amber 9 [25].
Modeling of the polymer folding into coil was carried
out in implicit solvent. The use of implicit solvent was
realized with application of Hawkins-Cramer-Truhlar
(HCT) model [26] within Generalized Born/Solvent-
Accessible Surface Area (GB/SA) formalism [27] in the
presence of 0.1 M NaCl. The General Amber Force Field
(GAFF) [28] was utilized for calculating interatomic
interaction energy between the polymer atoms. At the
beginning of MD simulations in implicit solvent (GB–
MD), the models energy was minimized using 250 steps of
the steepest descent followed by 250 steps of conjugate
gradient. Then gradual heating to 300 K during 20 ps was
performed. To avoid wild fluctuations into the studied
systems at this stage, weak harmonic restrains were used
with a force constant of 5 kcal 9 mol-19A˚-2 for all
atoms, excepting hydrogen. The SHAKE algorithm [29]
was applied to constrain the bonds to hydrogen atoms that
allowed using a 2 fs step. Dielectric constants of 1 (inte-
rior) and 80 (exterior) were employed in GB–MD simu-
lations. The production phase of GB–MD simulations was
carried out until the radius of gyration of the coil wasn’t
counterbalanced (about 10 ns). Then such conformation of
a coil, which corresponded to an energy minimum, was
chosen for further researches. To control the temperature,
the Langevin thermostat with the collision frequency of
1 ps-1 was used.
Interactions between the synthetic polymers and the
gp41-derived target were investigated with account of
solvent influence, taking the solvent in an explicit form.
The explicit (TIP3P) [30] solvent simulations were per-
formed in a cubic water box with periodic boundary con-
ditions imposed. To calculate interatomic interaction
energy the necessary parameters for all atoms were taken
from the force fields ff03 [31] and GAFF [28] mentioned
above. The negative charges were neutralized by adding
Na? ions randomly. The complexes were minimized prior
to the simulations. Firstly, the locations of the solvent
molecules (and ions) were optimized for 1,000 steps (500
steps of a steepest descent minimization followed by 500
steps of a conjugate gradient minimization) with all the
solute atoms, being restrained to their positions with a
force constant of 500 kcal 9 mol-19A˚-2. Then, the
complex structure was optimized without any restriction
for 2,500 steps (1,000 steps of steepest decent followed by
1,500 steps of conjugate gradient). Subsequently, a gradual
heating to 300 K over 20 ps was performed. To avoid wild
fluctuations in the system at this stage, weak harmonic
restraints with a force constant of 10 kcal 9 mol-19A˚-2
were used for all atoms with the exception of the solvent
atoms. As well as in a case of the solvent in an implicit
form all bonds to hydrogen atoms were constrained using
the SHAKE algorithm, which allowed a time step of 2 fs.
The non-bound 1–4 van der Waals and electrostatic inter-
actions were scaled by standard Amber values
(SCEE = 1.2, SCNB = 2.0). The cutoff for van der Waals
interactions was set to 12 A˚ during minimization and
heating, and 10 A˚ during following MD simulations. Long-
range electrostatics was calculated using the particle mesh
Ewald method [32]. The MD simulations in a production
phase were performed at p = 1 atm by using the Berend-
sen barostat with isotropic position scaling (NTP) = 1,
compressibility of the system (COMP) = 44.6 (default),
pressure relaxation time (TAUP) = 2 ps, and keeping the
T = 300 K under the control of the Langevin thermostat
with a collision frequency of 1 ps-1. The trajectory length
was 80 ns. Snapshot visualization was performed using
VMD [33, 34]. The snapshots were taken every 0.1 ns. For
hydrogen (H) bond identification and analysis the follow-
ing criteria of the H bonds recognition and approval were
applied: a donor–acceptor distance of 3.5 A˚ and an angle
cutoff of 30.
MM–GBSA scoring energy of MD simulation
In this investigation the MM–GBSA method was used to
calculate the binding free energy of complex state. Within
this approach, the binding free energy of a complex was
calculated in accordance with the formula (1):
DGbind ¼ GcomplexGtargetGligand ð1Þ
where Gtarget, Gligand and Gcomplex were the energies of the
target ([HR1]3 complex), ligand (model of polymer I) and
complex (between the target and the ligand), respectively.
The free energy of complex oneself and its each com-
ponent were scored by the following formula (2):
G ¼ EMM þ GsolTS ð2Þ
where EMM, Gsol and TS were total mechanical energy of
the molecule in gas, the free energy of hydration and
entropic contribution, respectively. EMM was calculated as
the sum of electrostatic, van der Waals energies and energy
of internal strain (bonds, angles and dihedrals) by using a
J Comput Aided Mol Des (2014) 28:647–673 651
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molecular-mechanics approach. Gsol was calculated as the
sum of polar Gpolar and nonpolar Gnonpolar terms, where the
electrostatic contribution to the hydration energy Gpolar
was computed with applying a GB approach [27] through
the algorithm developed by A. Onufriev, D. Bashford and
D. A. Case (OBC) [35, 36] for calculating effective Born
radii. The nonpolar component of hydration energy
Gnonpolar (including a solute–solvent van der Waals inter-
action and energy required for forming cavity being equal
of solute volume in solvent) was calculated by using the
formula: Gnonpolar = a 9 SASA, where SASA was solvent
accessible surface area computed with application of
LCPO method [37], and a was set to
0.00542 kcal mol-1 A˚-2. Because of very high confor-
mational capacity of the polymeric ligand, it was difficult
to score a contribution to entropy change at the expense of
change of conformational mobility. Therefore it was
decided not to consider the change of entropy in free
energy. It was suggested also that change of internal energy
of the target and the ligand contributed to the energy of
binding much weakly than other kinds of energy, and
therefore, this change was excluded from a consideration as
well. For each system snapshots taken from a single tra-
jectory of the complex, the MD simulation was used for the
calculations of the binding free energy. Dielectric constants
for calculating in gas-phase and water-phase were set to 1
and 80, respectively.
For an estimation of contacts of a polymer (as a whole)
and its separate components with a target the following
definition of the ‘‘contact’’ was applied: a contact of
(fragment of) polymer with target should be considered as
the contact taken place, if at least anyone couple atoms
(including the hydrogen) appeared so that one of the atoms
belong to the target, and another to the (fragment of)
polymer, and if the distance between these atoms became
less or equal to some critical value d. In this studying the d
was taken equal 3 A˚.
Results and discussion
Polymeric ligands’ models in various starting positions
to viral target
Taking into account the previous docking results (and their
correlation with in vitro anti-HIV evaluations data), the
models M11 and M11?3dNb (Scheme 2) were studied as the
representative fragments of anchor-free and anchor-con-
taining polymeric chains, respectively.
The first model (without pendant anchors) is related to
moderately anti-HIV-1 active kind of the polymeric com-
pounds I (X = OH/ONa, 100 %), whereas the second
model simulates the most active structure among the
compounds I (X = OH/ONa, 92–94 %, and dNb, 6–8 %),
possessing the top anti-HIV activity in vitro [7, 9] in good
correlation with the highest binding energy in the docking
[9, 16]. In accordance with the docking results-based pre-
diction (Fig. 3, Step 3) the eleven monomers (n = 11) in
the polymeric chain of the tried models should be enough
for both axial (n = 5–6) and one-level belting (n = 9–12)
modes of binding the target. And in case of the M11?3dNb
the existence of exactly three active (dNb) anchors provide
the docking-prognosticated possibility of the modeled
molecular structure to occupy either three-level (L1–L3)
cavities along the target’s a-helix (axial connection) or
triplet cavities around the every level (belting).
To verify the binding sites and ligands’ orientations
defined via docking, the MD modeling was performed,
using various starting positions (SP) of the polymeric
chain. Besides, the SP variations were tested to find whe-
ther the modes of binding between the ligands and target
depended on the SP conditions as well as to estimate a
comparative efficiency of the different possible modes
[38]. The first type of SP (SP1) was the polymeric chain
linearly unfolded along the target’s a-helix, using the M11
or M11?3dNb models. In the second type of start (SP2) we
dealt with the three anchors containing model M11?3dNb,
pre-folded in coil that contacted with the target near the
one of a-helixes. And in the third type of the start (SP3) we
tested the unfolded polymeric chain M11?3dNb oriented
transversely to the target. The MD simulated development
of the positions SP1, SP2 and SP3, illustrated by some
snapshots within the simulated time (80 ns), are shown in
Fig. 4a–c, respectively.
The MD evaluation of the models M11 (not shown) and
M11?3dNb (Fig. 4a) from longitudinal (axial) starting
position SP1 confirmed evidently the docking-predicted
capacity of both anchor-free and anchor-containing poly-
meric ligands I to be effective binding agents in axial
direction along the target’s a-helix within all three levels
(L1–L3) of cavities. An analogous result was observed if
instead of the unfolded chain M11?3dNb its coil-type con-
formation was tested (see Fig. 4b). On the contrary, a
transversely oriented starting position of unfolded
M11?3dNb chain (located near L1 pockets of target) dis-
played tendency to belt the target intensively covering at
least two a-helices exactly at the L1 pockets region
(Fig. 4c). The last result well correlates with docking-
predicted belting mode of interaction if the polymeric
chains I are equipped by active pendant anchors (Fig. 3).
An analysis of the ligand–target conformations/snap-
shots development from the variable starts (Fig. 4)6 leaded
6 Within the 80 ns the 800 target-ligand conformations were
generated via MD simulation for every SP, and only several from
them are demonstrated in Fig. 4.
















































































Scheme 2 The anchor-free (M11) and anchor-containing (M11?3dNb) fragments of polymeric chains. Note In contrast with the pendant anchors
(Anc) every single anionic structural unit repeated itself (11 times) along the polymeric chain backbone we designed as the BU
Fig. 4 MD-simulated interactions between the M11?3dNb and the [HR1]3 target for the different starting positions: a SP1, b SP2, and c SP3. On
the left a dynamics of every anchor–target distances, and on the right snapshots
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to statement of the following facts with preliminary
conclusions:
1. during the full time of the MD simulations the
presence of the synthetic polymers’ models M11 or
M11?3dNb (as ligands) didn’t disturb main self-organi-
zation of the biopolymeric (protein-type) target that
preserved a stable three a-helix 3D structure [HR1]3 in
conformations closely related to one, early tested as a
rigid crystal via the docking [16] (Fig. 2); this [HR1]3
stability under the MD simulated physiologically
relevant temperature confirms, particularly, a validity
of the target 3D structure application for the early
considered docking-based pre-modeling in respect of
the viral target and the tested type of synthetic
polymers as ligands;
2. SP1 and SP2 conditions resulted in axial binding along
the target, whereas SP3 demonstrated tendency toward
belting. Together these computer-aided data obtained
by MD from all starting positions (SP1–SP3) well
correlated with the docking predicted modes of the
target binding (Fig. 3);
3. MD generated conformations were also in good
correlation with the docking-determined epicenters of
active interactions between the ligands and the target,
including the binding priority of the L1 pockets region
and additional binding potency of the L2 and L3
cavities too.
Confirming the docking results in general, the MD
modeling (in comparison with the docking) opened many
new aspects of various specific target-ligands contacts and
their multipoint cooperation in view of time evolution and
the time-accumulated statistic data. The significant details
and tendencies are considered below.
Dynamic evolution of distances between ligand’s
and target’s substructures
Very interesting aspect (undetectable via docking) is evo-
lution of the various intermolecular contacts in dynamics.
Particularly, the diagrams of ligand’s Anc(s)–target dis-
tances dynamics of the M11?3dNb model (Fig. 4) shown that
at least two from three Anc(s) achieved stable contacts with
target during very short time—by the first 1–3 ns (from the
varied starts). And then the slightly fluctuating but enough
stable contacts were kept mainly over whole period of MD-
simulation (80 ns). This fact indicated that the pendant
anchors (linked with polymeric chain through flexible
bridges –Y– = –NH–CH2–) possessed great mobility for
rapid finding vacancies suitable for the binding stabilization
on the target’s surface. Such capability of anchors to be
quickly contacting sensors of the ligand–target interactions
should be taken into special consideration (see below, the
section ‘‘MD-based revision of the polymeric platform
advantages for drug design’’).
Statistics of contacts between structural components
of target and ligands
More detailed understanding of the ligand-target interac-
tion under various starting conditions can be extracted from
a statistical analysis of the MD-simulated multipoint con-
tacts between structural components of the ligand and
amino acid residues of the target. The corresponding
examples are represented in Fig. 5 and Table 1.
The MD-based investigation of quantitative attendance
of the target’s amino acid sites by various structural com-
ponents of the tested ligands leaded to the following
observations.
Target’s amino acids accessibility depending on their
positioning in a-helixes
First of all, we would like attract the attention to differ-
ences between the target’s amino acids in relation to
variety of their positioning within the repeat heptad motifs
(… a, b, c, d, e, f, g,…) of a-helixes and native involve-
ment of amino acids into coiled-coil self-assembly of the
viral target. For the both models of ligands their compo-
nents practically didn’t attend the amino acids in the ‘‘a’’
and ‘‘d’’ positions (Fig. 5). This tendency is in good
agreement with well known [11, 12, 39] involvement of the
noted amino acid residues in self-aggregation of the a-
helixes together—to the coiled-coil type three-helix com-
plex [HR1]3 (Fig. 2). As it was mentioned above, this
complex kept stability during the full MD simulations.
Therefore, using a binding potentiality for the target’s
coiled-coil self-organization, these amino acids (I548,
Q552, L555, I559, Q562, L566, T569, I573, L576 and
I580) should be restricted for interactions with the external
ligands. No intensive attendance of the a and d—positioned
sites by any components of the MD-tested ligands (from all
SP) was recorded, for exclusion only the several cases.7 In
the most considerable cases of Q552 and L576 the both
amino acids were located in epicenters of the cavity/pocket
(at L3 and L1, respectively). So, an enhanced accessibility
of these amino acids to contacts with ligands can be
explained by possibilities of ligand’s structures to penetrate
into the cavity/pocket toward the polypeptide backbones of
the target-forming helixes.
7 The Q552 of the 1st helix was attended by hydrophobic anchors of
M11?3dNb started from SP1b and SP2a; one of hydrophobic anchors
contacted also with I548 (from the start SP2) and with L576 (from the
start SP3); and anionic backbone units of the ligand polymeric chain
also had an interactions with L576 (if the M11?3dNb started from SP2).
654 J Comput Aided Mol Des (2014) 28:647–673
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Fig. 5 Statistics of the ligand–target contacts within 80 ns in separate
consideration of an attendance of every amino acid (aa) among
sequence of the [HR1]3 target (including the three identical 36 aa a-
helixes, formally designed as 1st, 2nd, and 3rd) by various compo-
nents of the ligands: anionic units of polymeric chain backbone with
X = OH/ONa (yellow columns) or hydrophobic pendant anchors
(X = dNb), the first Anc (blue columns), second Anc (crimson
columns) and third Anc (black columns). SP1a—start from Anc-free
M11 unfolded along the 1st helices; SP1b—start from similarly
oriented Anc-containing M11?3dNb (Fig. 4a); SP2—the M11?3dNb
started from a coil connected with target near 1st helix (Fig. 4b);
SP3—the same ligand model started from unfolded conformation
transversally to the target near the L1 floor of main pockets triplet,
from the 1st helix side (Fig. 4c). The below shown scheme of the
[HR1]3 amino acids ordering indicates the heptad repeat positions
a and d involvement in the coiled-coil self-aggregation, whereas
positions b, c, e, f and g are accessible to contacts with ligands
J Comput Aided Mol Des (2014) 28:647–673 655
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Other amino acids in positions ‘‘b’’, ‘‘c’’, ‘‘e’’, ‘‘f’’ and
‘‘g’’ of the repeated heptads (Fig. 5) form an interface well
accessible for the target–ligands interactions. Total statistic
(for M11 from SP1, and for M11?3dNb from SP1, SP2 and
SP3 cases) resulted in the following partial contributions to
the amino acids attendance, depending on positioning in
the heptads (% of all contacts): a (1.3), b (24.6), c (18.7),
d (2.2), e (12.6), f (29.5) and g (11.1).
Contacting activity of different levels (L1–3) of the target’s
cavities/pockets
The ligands–target contacts intensity was different for the
different levels L1/L2/L3 of target’s triplets of cavities
(Fig. 5, Table 1). The largest—L1 pockets were most
attractive for the contacting. They became fully dominant
region in interaction with M11?3dNb, providing 96.2 % of
total contacts (Table 1), if the ligand model started from
the transversal position located near the L1. Therefore, the
MD confirms the docking-predicted role of the L1 pockets
of target as a general locus sensitive to the ligands
I attacks.
However, the other levels (L2 and L3) cavities were
capable of substantial contributions to the contacts, when
the starting position of ligand didn’t create a favourable
precondition for the level L1 attendance. For instance, the
start SP2 resulted in nearly equal partial contributions of
every level (Table 1). The high potentiality of L2/3 cavities
is in a good correlation with data of the docking pre-study
as well. The marked activity of L2 and L3 cavities in
additional multipoint binding the ligands was predicted by
docking on the condition that the ligands were not small
molecules (considered by other authors) but the polymeric
compounds (tested in our work). It was found that only the
poly/oligo-meric compounds, such as I (Scheme 1, when
n C 4), were able to cover the full nano-scale (C5.1 nm) of
the all three levels of cavities simultaneously (Fig. 3).
Role of the ligands’ anionic chain ([BU]11)
and hydrophobic pendant anchors (Anc1–3)
The MD-based statistics demonstrated important peculiar-
ities determined by the cooperation of acidic (anionic-
ionizable and H-bond capable) polymeric chain backbone
Table 1 The multiplicity of attendance of the target’s amino acids by
ligand’s components: 80 ns-accumulated statistic data of the ligand–
target contacts quantity for partial contributions of anionic units of
polymeric chain backbone (BU) and each hydrophobic pendant
anchor (Anc1, Anc2 and Anc3) of the ligands to connections with the
target’s amino acids of the all cavities/pockets levels (L1, L2, L3) of
every HR1 helixes
L2 556-565 1051/1051 896 387 659 0 1046/1942 1604 597 2468 70 3135/4739 408 0 3 174 177/585
L1 567-581 4039/4039 4975 0 2279 50 2329/7304 2792 0 0 283 283 /3075 3002 0 2999 2167 5166/8168
2nd L2 556-565 0 /0 0 0 0 0 0/0 0 0 0 0 0 /0 1 0 0 0 0 /1
L1 567-581 0 /0 30 0 0 0 30/30 1862 0 0 0 0 /1862 3925 0 2798 0 2798/6723
3rd L2 556-565 54 /54 0 0 0 0 0/0 0 0 0 0 0/0 0 0 0 0 0/0
L1 567-581 16 /16 0 0 0 0 0/0 0 0 0 0 0/0 10 0 0 0 0/10
L2 556-565 1105 /1105 896 387 659 0 1046/1942 1604 597 2468 70 3135/4739 409 0 3 174 177/586
L1 567-581 4055 /4055 5005 0 2279 50 2359/7334 4654 0 0 283 283/4937 6937 0 5797 2167 7964/14901
Target, 
the [HR1]3
Ligands and their starting positions* to the viral target







SP1* SP1* SP2* SP3*
BU /all 














L3 549-554 1059/1059 1441 2104 0 0 2104/3545 2257 2177 0 0 2177/4434 0 0 0 0 0 /0
sub-total: 6149 /6149 7312 2491 2938 50 5479 /12791 6653 2774 2468 353 5595/12248 3410 0 3002 2341 5343 /8753
L3 549-554 0 /0 0 0 0 0 0/0 0 0 0 0 0 /0 0 0 0 0 0 /0
sub-total: 0 /0 30 0 0 0 30/30 1862 0 0 0 0/1862 3926 0 2798 0 2798/6724
L3 549-554 213 /213 10 481 0 0 481/491 0 536 0 0 536/536 0 0 0 0 0/0
sub-total: 283 /283 10 481 0 0 481/491 0 536 0 0 536/536 10 0 0 0 0/10






t L3 549-554 1272 /1272 1451 2585 0 0 2585/4036 2257 2713 0 0 2713/4970 0 0 0 0 0/0
* The various starting positions of ligand to target: SP1—unfolded along the target’s 1st helix, SP2—coiled near the 1st helix and contacted with
pockets locus L1 of the target, and SP3—unfolded transversely to the target near its pockets locus L1
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units (BU) and side-grafted to the polymeric chain pendant
anchors (hydrophobic Anc1, Anc2 and Anc3). An estima-
tion of relative contributions of the both kinds of structural
species into the ligand potency to interact with the target
was analyzed from comparative study of the fully acidic
model M11 (containing 44 acidic groups, the X = OH/O
-
Na? 100 %) and the derived model M11?3dNb, where only
3 from 44 (7 %) side groups were substituted by the
anchors. A comparison of the anchor-free with anchor-
containing models in their interactions with the viral target
(Fig. 5) resulted in statement of the fact: under similar
starting position (SP1) the anchor-‘‘equipped’’ model
generated significantly more intensive contacts with the
target. From data summarized in Table 1 one can see, that
degree of total attendance of target’s amino acids by
M11?3dNb (13,312 contacts) was more than twice higher
than by M11 (6,432 contacts).
Interestingly, losing the three anionic side-groups
(because of them substitution by the hydrophobic pendant
anchors) didn’t lead to decreasing a multiplicity of contacts
of anionic BU with target: 6,432 contacts of M11, as
compared with 7,352 contacts of M11?3dNb. The similar
enhanced contacting potency of the anionic backbone of
M11?3dNb was recorded for other starting conditions as
well: 8,515 (SP2) and 7,346 (SP3) total contacts of BUs
with target (Table 1). Besides, the anchors themselves also
strongly contributed to the contacting: 5,960 (SP1b), 6,131
(SP2) and 7346 (SP3) additional contacts with target (ibid).
Inserting the anchors in polymeric ligand altered a
general distribution of contacts of the anionic backbone
components with target not significantly (compare distri-
bution of yellow columns of SP1a and SP1b, Fig. 5).
Therefore, from the MD statistics-based point of view, the
pendant anchors (grafted to polymeric chain) didn’t crucially
compete/interfere with the polymeric chain itself (the
backbone) for binding the target’s amino-acid sites. Quite the
contrary, the anchors promote a synergetic effect, amplifying
the degree of BU–target contacts, plus the anchors (Anc1,
Anc2 and Anc3) themselves contributed an additional
capacity to multipoint connection with the viral target
(Fig. 5; Table 1). This MD statistic results are in good
agreement with the docking modeling: the anchor containing
models provided more powerful binding with the target, as
compared with anchor-free models [9, 16]. Moreover,
together both MD and docking data correlate very accurately
with the data of in vitro evaluations of real polymeric com-
pounds of the series I (where exactly the dNb containing
experimental samples were*12-folds more anti-HIV active
than their anchor-free precursors [4, 9]).
In sum of all MD-tested SP (Fig. 5) the target’s amino
acid residues priority to be attended by BUs and/or Anc1–3
can be classified for the following three groups: (1) acids
preferably connectable with anionic units of polymeric
chain (S546, Q550, R557, R579,8 and L581); (2) acids
more sensitive to pendant anchors (Q551, L556, E560,
A561, and G572); and (3) ‘‘plural’’ acids actively attended
by both polymeric chain’s units and anchors (V549, N553,
H564, Q567, L568, V570, W571, K574, Q575, Q577, and
A578). As a whole, the activity of these amino acid resi-
dues is in a good correlation with docking predicted
binding sites. For example, both docking and MD defined
identical main sites of active contacts with ligand models:
R557 and R579 (preferably with the acidic BU compo-
nents) and K574, A578, W571, and V570 (with both BU
and Anc(s)).
Influence of starting ligand-target orientation
on the ligand-target contacts distribution
The Fig. 5 visually demonstrates that both anchor-free
anionic chain M11 and anchor containing derivate
M11?3dNb starts from unfolded state SP1 (axially to the 1
st
helix of viral target) leaded to intensive contacts with
amino acids just of the 1st helix. The anchor-containing
model provided more intensive contacts than M11, v.s.
An analogous statistics of the M11?3dNb ligand was
observed for the start SP2—from coil state near the middle of
the 1st helix. Both unfolded (SP1) and coiled (SP2) starting
conformations leaded to similar contacts with the target. The
initially unfolded conformation developed toward partial
folding, and the coil conformation was in progress toward
partial unfolding along the 1st helix. But the both starting
conformations resulted in similar situations by the 80 ns of
the MD simulation (Fig. 4, snapshots series a and b,
respectively). Within the 80 ns the coiled start SP2 devel-
opment accumulated a statistics of contacts preferably with
the target’s 1st helix (like the SP1 start, but all contacts were
distributed between various levels L1–3 and helixes rather
more evenly than in the case of SP1 start) (Table 1).
In contrast with the mentioned starts, the conformation
of M11?3dNb unfolded transversally to the target near L1
didn’t develop contacts with target along the full length of
1st helix. The ligand’s interactions with target were con-
centrated around the L1 pockets of 1st and 2nd helixes
generally (SP3, Fig. 5; Table 1).
The significant influence of starting orientation on a
mode of the ligands–target interactions (discovered by the
considered MD simulation) could not be found evidently
via docking. Clearing this aspect, the MD at the same time
confirms the docking predicted possibilities for the suffi-
ciently long chain ligands I. The binding capability of both
axial (along one helix) and belting (around L1 pockets
within at least two helixes) contacts were observed.
8 The cationic ionisable R557 and R579 is one of the most active
amino acid sites in binding the anionic units of polymeric chain.
J Comput Aided Mol Des (2014) 28:647–673 657
123
Statistics and dynamics of H-bonds
Hydrogen bonds (H-bonds) are of great importance in
molecular biology, and so the H-bonds role in the modeled
system of the protein-type target [HR1]3 interactions with
the synthetic polymeric ligands I was taken into special
consideration. First of all, this problem was considered in
respect of H-bonds network for self-organization of the
protein target (intra-stabilization of the coiled-coil [HR1]3
complex). After that the target’s capability-implementation
for H-bonds formation with external ligands was analyzed
in focus for specificity of the polymers series I.
Some definitions applied in this article for the H-bonds
analysis (in detail see supplementary material 1) QHb—
Quantity of H-bonds within a single snapshot; DHb—
degree of H-bonds formation (H-bonding) statistically
averaged for a time interval of MD simulation:
DHb ¼ RmQiHb=m ð3Þ
where the QHb
i —amount of H-bonds for analyzed pool of
N/O atoms in i’th target/ligand (or target ? ligand) con-
formation (in i’th single snapshot), m—number of the MD
generated conformations (snapshots) taken into account for
analysis, and the Rm QHb
i —total amount of the H-bonds
within the m snapshots.
After the calculations for all possible pairs of N and O
atoms, these data sets were treated for quantitative esti-
mation of summarized amounts or degrees of H-bonds as
well as for analysis of separate contributions of various
sub-structural components of ligands and target to the
H-bond network. To differentiate various analytically rel-
evant series of H-bonds we introduced the following defi-
nitions for H-bonds classification, depending on the
H-bond forming atoms belonging: M/M-H-bond between
atoms from main chain (the polypeptide backbone) of
target; M/S-H-bond between atom(s) of the main chain and
atom(s) of an amino acid residue side chain or S/M-H-bond
between atom(s) of an amino acid residue side chain and
atom(s) of the main chain; S/S-H-bond between atoms
from the side chains of target; M/L-H-bond between
atom(s) from target’s main chain and atom(s) of ligand; S/
L-H-bond between atom(s) from a side chain of target and
atom(s) of ligand
H-bonds of the target’s self-organization in the coiled-coil
[HR1]3 complex
An analysis of H-bonds network for the protein target self-
organization in presence of the polymeric ligand can be
extracted from the data represented in Table 2 by an
example of MD simulated [HR1]3–M11?3dNb system from
start SP1.
The first very visible difference of H-bonds organization
is observed between the intra- and inter-helix interactions.
All H-bonds of main polypeptide backbone (M/M) con-
tribute to intra-helix stabilization exclusively (1st–1st/2nd–
2nd/3rd–3rd helix). And no M/M H-bonds between dif-
ferent helixes (1st–2nd/1st–3rd/2nd–3rd helixes) were
recorded. The amino acid residues order in the M/M
H-bonds formation within the each a-helix polypeptide
(Ile548-Arg579)9 backbone conforms in general with the
classic Pauling–Corey–Branson alpha helix, in which
every backbone N–H group donates a H-bond to the
backbone C=O group of the amino acid four residues
earlier (i ? 4 ? i H-bonding) [40].
In the MD simulation some dynamically-rearrangement
fluctuations of the helix construction were occurred at the
physiologically relevant temperature. A total probability of
these reversible aberrations from the classical a-helical
architecture of H-bonds was B11 %. In spite of this, the
classic a-helix order for various amino acid residue pairs
i ? 4 ? i (within the considered 32 amino acid sequences of
the [HR1]3 helixes triplet) was locally realized by 30–99 %.
Thus, the H-bound potentiality of the target’s polypep-
tide main chains is mobilized for the a-helix (413-helix)
self-formation. It involved the great amount of the M/M-
type H-bonds (DHb = 102.72), the main part of full intra-
[HR1]3 H-bonds degree (DHb = 125.27), Table 2.
As the polypeptide main chain M/M H-bonds are used in
the a-helix intra-organization completely, therefore, this
source is excluded from any external inter-helixes or any
target-ligand H-bonding. So the external part of H-bonds
network requires an involvement of exactly the side chains
of a-helixes. Within the concrete amino acid sequence of
the target’s a-helixes, only ‘‘H-bond competent’’ N/O
atoms in the side chains could be considered as the suitable
points. Such amino acid side chain’s capabilities are shown
in Table 3 as the frame-marked data.
Thus, the H-bonds capability of the viral target’s helixes
is distributed along their polypeptide polymeric chains,
depending on chemical nature of amino acid residues,
represented in Table 3. The MD statistics estimation
resulted in more decreased values of DHb. But the relative
contributions of various amino acids to the S/S H-bonding
were in good proportions with the theoretical abilities
generally: the most S/S H-bond potential residues provided
the main contribution to the H-bonds formation (in the
order of R [ Q, N [ K [ W, T, see in Table 3).
However, not only chemical nature but the positioning
of the amino acids in the heptad repeat motifs (… a, b, c, d,
9 The two N-terminal (Ile580 and Leu581) and two C-tail (Ser546
and Gly547) amino acid residues of every from three a-helixes were
excluded from the consideration because of edge effects of the target
cutoff (zones of a priori inadequacy between modelled and natural 3D
structure of the target).
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e, f, g …) of helixes plays an essential role in the S/S (and
S/M or M/S) type H-bonds accomplishment. In the first
place the positions a and d should be taken into account as
theoretically predictable points for selective inter-helix
contacts supported the self-aggregation from separate a-
helixes toward their complex 3HR1 ? [HR1]3 (Fig. 2 and
5). Molecular architecture of this viral complex is a special
(triplet type) case of the classic coiled-coil self-assembly of
a-helixes [41], where the side chains of a and d positioned
residues are involved into the inter-helical aggregation [11,
12, 39], but not in intra-helix contacts mainly.
Really, under the MD simulation the side chains of
amino acid residues at a and d positions played no sig-
nificant role in the intra-helix H-bonding. Simultaneously,
just these species made predominant contribution to the S/S
type H-bonds between pairs of three helixes co-aggregated
together in the [HR1]3. The total degree of S/S type
H-bonds was very slight (DHb = 0.002) in the intra-helix
interactions [1st $ 1st] ? [2nd $ 2nd] ? [3rd $ 3rd],
just as this value became many times increased
(DHb = 3.03) within the interactions between adjacent a-
helixes [1st–2nd] ? [1st–3rd] ? [2nd–3rd] (Table 2).
In contrast with the mentioned situation, the side chains
of amino acid residues in the heptad repeat positions b and
f were most active for intra-helixes H-bonding
(DHb = 3.58), but fully inactive for any H-bonding
between the adjacent a-helixes (DHb = 0.00) (Table 2).
The next type, the M/S or S/M, of H-bonding between
N/O atoms of main polypeptide chain and complemented
O/N atoms of a side chain were more preferable for the
intra-helix stabilization (DHb = 11.42) than for the inter-
helixes co-aggregation (DHb = 1.66) (Table 2).
Together all considered types of the target own network
of H-bonds support the self-stabilization of the HR1
polypeptide chains in the a-helix state (mainly via M/M
H-bonds) as well as these a-helixes triplet self-assembly to
the coiled-coil [HR1]3 complex (using S/S and S/M or M/S
H-bonds).
It is very important to note that this complex (as the viral
target for therapeutic intervention by the polymeric ligands
Table 2 Degree of the H-bonds formation (DHb) within the [HR1]3
complex for intra-a-helix (1st–1st/2nd–2nd/3rd–3rd) and inter-a-
helixes (1st–2nd/1st–3rd/2nd–3rd) contacts in view for involving
amino acid residues at different heptad repeat positions (a–g) trough
main polypeptide backbone or side-chain atoms (O or N)
The case of M11+3dNb from SP1
1st 1st helix 2nd 2nd helix 3rd 3rd helix
M/M S/S M/S S/M M/M S/S M/S S/M M/M S/S M/S S/M M/M S/S M/S or S/M
a 5.82 0.00 0.04 0.29 6.16 0.00 0.60 0.02 5.85 0.00 0.10 0.08 17.83 0.00 1.14
b 5.94 0.63 0.00 0.42 4.72 0.50 0.02 0.25 4.82 0.69 0.02 0.33 15.48 1.82 1.05
c 4.14 0.10 0.26 0.06 3.72 0.09 0.05 0.11 3.52 0.33 0.09 0.08 11.37 0.52 0.65
d 5.17 0.00 0.29 0.88 4.95 0.00 0.03 0.78 5.37 0.00 0.05 0.80 15.49 0.00 2.81
e 5.87 0.03 0.55 0.18 5.64 0.05 0.27 0.64 5.59 0.04 0.38 0.12 17.10 0.13 2.14
f 5.66 0.61 0.10 0.04 4.40 0.46 0.11 0.04 4.36 0.68 0.08 0.04 14.43 1.75 0.41
g 3.76 0.09 0.97 0.35 3.43 0.11 0.85 0.08 3.85 0.30 0.86 0.11 11.03 0.50 3.22
36.35 1.47 2.21 2.21 33.02 1.21 1.93 1.93 33.35 2.04 1.57 1.57 102.72 4.72 11.42




M/M S/S M/S S/M M/M S/S M/S S/M M/M S/S M/S S/M M/M S/S M/S or S/M
a 0.00 0.28 0.00 0.00 0.00 0.23 0.89 0.12 0.00 0.56 0.01 0.00 0.00 1.07 1.02
b 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00
c 0.00 0.25 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.06
d 0.00 0.70 0.07 0.01 0.00 0.91 0.00 0.00 0.00 0.35 0.06 0.09 0.00 1.96 0.23
e 0.00 0.00 0.00 0.00 0.00 0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.56 0.00
f 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
g 0.00 0.81 0.01 0.33 0.00 0.00 0.01 0.00 0.00 0.11 0.01 0.00 0.00 0.91 0.35
total 0.00 2.03 0.14 0.34 0.00 1.71 0.90 0.12 0.00 1.01 0.08 0.09 0.00 4.75 1.66
total H-bonds degree for M-/S-related distribution within whole [HR1]3 102.72 9.47 13.08
full H-bonds degree for the [HR1]3 self-organization 125.27
Notes The columns take into account H-bonds between N/O atoms of main polypeptide backbone (M) or of amino acid’s side-chain (S) for
separate estimation of ‘‘main chain $ main chain’’ (M/M), ‘‘side chain $ side chain’’(S/S) and ‘‘main chain $ side chain’’ (M/S or S/M)
H-bonds; the two N-terminal (Ile580 and Leu581) and two C-tail (Ser546 and Gly547) amino acids of every from three a-helixes were excluded
from the estimation because of edge effects of the target cutoff (zones of a priori inadequacy between modelled and natural 3D structure of the
target)
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I) was stable at the MD-simulated physiologically relevant
temperature in the presence of ligand M11?3dNb. Moreover,
comparing partial saturation of every a-helixes by the
H-bonds (Table 2) with the statistic of the ligand-target
contacts (Fig. 5; Table 1), we can conclude that the intensive
contacts of the M11?3dNb ligand with the 1st helix didn’t
suppress this helix involvement into the H-bonds-mediated
self-assembly. The 1st a-helix M/M, S/S and M/S or S/M
contributions to the target own H-bonding were no less than
(or comparable with) similar contributions of 2nd and 3rd
helixes, which were free of active connection with the
polymeric ligand under the SP1 start (Table 2). An analo-
gous situation in MD trials of the M11 was observed as well.
Polymeric ligands capacity of H-bonding for self-
stabilization or interaction with target
The alicyclic dNb anchors don’t possess any atoms/groups fit
to H-bonding (i.e., the dNb is H-bond inert specie). All H-bond
forming potential of the tested models of ligands concentrated
in the polymeric backbone [BU]11 (due to the 44 carboxy-
derived –COX groups plus 11 furan-coupled ether –O–
atoms). Both M11 and M11?3dNb ligands have enough potent
sets of ‘‘H-bond competent’’ sub-structures, allowing degree
of H-bonds up to DHb = 99, as maximum (Table 4). How-
ever, as demonstrated the MD-simulation, only low part of this
potency (DHb = 4.15–5.44) was used by the ligands for own,
intra-molecular, self-stabilization (Table 4).
This finding was quite expected as soon as the intra-
polymeric H-bonding could be depressed because of
repulsion between negative charges of the anion-ionizable
groups. Some relatively stable H-bonding was observed
between C=O and H–O atoms of carboxylic groups pre-
dominantly in neighbor positions of polymeric chain
(Scheme 3), where the H-bonds appeared within the flex-
ible (succinic acid—SA) moieties more frequently and
longer than at the rigid (cyclic—FU) fragments.
However, the main part of the ligand chain’s H-bonding
capability was remained as unused resource (vacancies)
accessible to intermolecular contacts. In theory, this
peculiarity of the tested polymeric ligands could provide
good preconditions for some additional H-bonds mediated
interference with the viral target.
On the other hand, the target itself also has accessible
‘‘H-bond competent’’ vacancies (in side chains of amino
acids). These vacancies are distributed among the three
levels (L1, L2 and L3) of cavities/pockets as the theoreti-
cally allowed maxima of DHb = 38.8 (within L3), 32.5
(within L2), and 50.5 (within L1) (calculated from the data
in Table 3). Based on this pre-calculation we could expect
the following priority of the cavities levels to be attractive
H-bonding niches for ligands: L1 [ L3 [ L2. In addition,
an electrostatic attraction between the ligand’s polyanionic
chain and target’s cationic side chains (Fig. 2) of lysine (on
L1) and arginine (on L1 and L2) residues should be taken
into account as well.
Table 3 ‘‘H-bonds competent’’ side chains* of 548–579 amino acid residues sequence of every a-helix from the helixes triplet constructed the
target [HR1]3 complex
* Within full amino acid sequence of single a-helix of target, the amino acids with ‘‘H-bonds competent’’ side chains are marked by frames, and
below the contained amount of H-bound competent atomic groups (N–H/C=N/O–H/C=O) as well as degrees of the S/S, S/M and M/S(plus S/M)
types of H-bonds are indicated by example of MD simulation of target in presence of M11?3dNb ligand from SP1 start
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Ligand–target H-bonds formation, depending on target’s
amino acids positions and nature
Above we demonstrated that the polypeptide backbone’s N
and O atoms are generally involved in a-helix self-for-
mation, and H-bond competent side groups of amino acids
in a and d positions (of repeat heptad) contribute to the
target self-assembly toward coiled-coil [HR1]3 complex.
However, the target could be accessible for H-bond con-
nection with any ligands, using other suitable vacancies at
side chains of amino acid residues in b, c, e, f, and
g positions of heptad repeat motifs, especially in respect of
H-bond active side chains (Table 3).
This theoretical prediction is in good agreement with the
MD generated experimental data: in Tables 5 and 6 one
can see the dominant role of side groups of the b/c/e/f/g
located Gln, Asn, Arg, His, Trp, and Lys in H-bonds for-
mation with O atoms of the polycarboxylic ligands M11 and
M11?3dNb. Simultaneously, no H-bond formation with
these ligands was registered for side chains of any amino
acids in the a/d positions of target.
Influence of ligand’s anchors on the ligand-target H-bonds
capacity
In spite of the alicyclic dNb anchors didn’t possess any
own H-bond competent atoms, notable indirect effects of
these H-bond-inert species on the H-bonding were
revealed. An influence of pendant anchors on the H-bonds
formation between the target and ligand can be estimated
by examples of the anchor-free M11 and anchor containing
M11?3dNb models in their comparative study at similar
starting condition, the S1, for instance.
Unexpectedly, the MD modeling shown that the sub-
stitution of three ‘‘H-bond competent’’ OH carboxylic
groups by the H-bond-inert dNb anchors in the [BU]11
polymeric chain resulted in no suppression of H-bonds
formation. Quite the contrary, approximately 40 % growth
of the ligand-target H-bonds intensity was observed
(Table 5). The anchor containing M11?3dNb (from SP1)
provided DHb = 6.44 as compared with DHb = 4.59
induced by the M11 without any anchors. An epicenter of
the H-bonds degree growth was located within the L1 niche
of the target’s pockets, with detectable switching the
H-bonds formation from L2 to L1 of the target’s cavities.
As the pendant anchors themselves can’t be direct partners
in H-bonding, the observed fact may be explained by an
enhanced tropism of the anchors to the hydrophobic pockets of
L1. Covalently linked to polymeric chain, the anchors entrain
the [BU]11 chain units toward this most attractive pockets,
resulting in the anchors-mediated amplification of the poly-
mer backbone H-bond contacts exactly in the L1 niche.
The similar synergetic effect of anchors was mentioned
above in relation to the anchors-mediated intensification of
all contacts between the ligand and the target (section
‘‘Role of the ligands’ anionic chain ([BU]11) and hydro-
phobic pendant anchors (Anc1–3)’’). This very interesting
discovery illustrates an opportunity of significant promo-
tion of synthetic polymeric chains activity to bind bio-
polymeric (protein) targets due to pendant anchors, even if
the anchors per se are not capable of H-bonding. Mecha-
nisms and drug-design applicability of the polymer-coop-
erative specific activity will be discussed below (section
‘‘MD-based revision of the polymeric platform advantages
for drug design’’).
A centipede-like movement of poly(carboxylic acid)chain
on the target surface
Possessing the oxygen-enriched chemical nature (44 car-
boxyl-derived –COX groups plus 11 ether –O– atoms,
multi-repeated along the 11-meric chain of BU units), the
relatively flexible polymeric backbone appeared very dis-
tinctive manner of interactions with the viral target in
searching an geometry-energy optimal adaptation. This
peculiarity can be defined as ‘‘a centipede-like effect’’ of
the polymeric chain movement on the viral target’s surface
due to the multiple H-bond active oxygen-based ‘‘legs’’.
And examples of such behavior were observed most evi-
dently in dynamics of contacts of target’s side chains with
Table 4 ‘‘H-bonds competent’’ atoms of the polymeric ligands and
degree of the intra-ligand H-bonding
The ligand models M11 M11+3dNb
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Scheme 3 Intra-molecular H-bonds in polymeric chain
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sequences of oxygen atoms along the polymeric chain of
ligands (via step-by-step analysis of sub-molecular contri-
butions to the S/L H-bonding).
For instance, the side chain of high active Arg557 (within
L2 of 1st helix) were involved in reversible stepwise
H-bonding with the following sequences of O atoms of
ligands models: O37,38,39,40,41,42,43 (M11 from SP1),
O27,28,29,30,31,32,33,-,-,36,37,38,39 (M11?3dNb from SP1),
O53,54,55,56,-,-,-,-,61,62,63,64,65,66,-,-,69 (M11?3dNb from SP2).
The Lys574 (within L1 of 1st helix) side chain was stepwise
filled by H-bonds with: O61,-,63,64,65,66,67 (M11 from SP1) and
O62,-,64,65,66,67,68,69 (M11?3dNb from SP1); the Arg579
(within L1 of 1st helix) side chain participated in H-bonding
with ligand’s oxygen motifs: O68,69,-,71,72,73,74 (M11 from
SP1), O27,28,29,30,31,32,33,-,-,36,37,38,39 (M11?3dNb from SP1),
O53,54,55,56,-,-,-,-,61,62,63,64,65,66,…69 (M11?3dNb from SP2), etc.
These contacts (and snapshot series analysis) demon-
strated reversible step-by-step translocations of the multi-
ple oxygen ‘‘legs’’ (of the flexible ligand’s chain) through
the H-bonds competent amino acids. The H-bond detect-
able points of amino acid residues, locally fixed on the
target’s surface, allow of sensing this movement.
Comparing the behavior of M11 and M11?3dNb models
(from similar start, the SP1), we found that anchors
rather assisted the main poly(acidic) backbone to be
contactable with target. The anchors facilitated an
involvement of more broaden diapasons of the oxygen
(‘‘legs’’) motifs of synthetic polymer chain in this
stepwise movement, amplifying an adaptability of the
ligand to the target. This evidence represents another
impressive example of mutual cooperation of BU and Anc
units in interaction with the target (see below, section
Table 5 Degree of H-bonds formation between the target’s amino acids and the ligand’s species (O atoms of BU)
Helix
↓
Cavities level L3 cavities L2 cavities L1 pockets
total
Amino acid Gln Gln Asn Asn Arg Gln His Gln Trp Lys Gln Gln Ala Arg 
heptad position
sequence position
f g b c f e f b f b c e f g
Q550 Q551 N553 N554 R557 Q563 H564 Q567 W571 K574 Q575 Q577 A578 R579
M11 + [HR1]3 from SP1
1st M/L - - - - - - - 0.01 - - - - - - 4.41S/L 0.32 - 0.51 - 1.93 - 0.05 0.18 0.01 0.28 0.43 0.004 - 0.69
2nd M/L - - - - - - - - - - - - - - 0S/L - - - - - - - - - - - - - -
3rd M/L - - - - - - - - - - - - - - 0.18S/L 0.06 0.08 - - 0.001 0.04 - - 0.003 - - - - -
Sum for the level: 0.97 2.02 1.60 4.59
M11+3dNb + [HR1]3 from SP1
1st M/L - - - - - - - 0.06 - - - - - - 6.44S/L 0.29 - 0.80 - 1.86 0.004 - 0.31 0.72 0.81 0.25 - - 1.34
2nd M/L - - - - - - - - - - - - - - 0S/L - - - - - - - - - - - - - -
3rd M/L - - - - - - - - - - - - - - 0.001S/L - 0.001 - - - - - - - - - - - -
Sum for the level: 1.09 1.86 3.49 6.44
M11+3dNb + [HR1]3 from SP2
1st M/L 0.05 - - - - - - - - - - - - - 4.72S/L 0.66 - 0.29 0.36 0.65 - 0.12 - - - 0.70 - - 1.90
2nd M/L - - - - - - - - - - - - - - 0.97S/L - - - - - - - - - 0.22 - 0.75 - -
3rd M/L - - - - - - - - - - - - - - 0S/L - - - - - - - - - - - - - -
Sum for the level: 1.36 0.76 3.57 5.69
M11+3dNb + [HR1]3 from SP3
1st M/L - - - - - - - - - - - - - - 2.05S/L - - - - - - 0.09 0.004 0.27 0.11 0.60 - - 0.98
2nd M/L - - - - - - - - - - 0.001 - 0.01 0.03 3.41S/L - - - - - - - 0.69 0.14 1.20 0.27 0.18 - 0.90
3rd M/L - - - - - - - - - - - - - - 0S/L - - - - - - - - - - - - - -
Sum for the level: 0 0.09 5.37 4.46
Notes The data are represented for the all MD-tested starting conditions (SP1–SP3) in dependence on nature of the involved target’s amino acid
residues and their positioning in a-helixes (1st, 2nd or 3rd), HR1 polypeptide sequence (compare with Fig. 2), heptad repeat motifs (a–g) and
cavities/pockets levels (L1–L3) in view of the target’s H-bond active centre location in the main polypeptide chain (M/L) or in side chains (S/L).
By the M/L we designate the H-bonds between target’s main polypeptide chain (–NH–CR1R2–CO–) and O atoms of ligand, and S/L designates
H-bonds of side chains of amino acid (the N/O atoms of R1/R2) with the same ligand. The ‘‘–’’ sign indicates that between the concrete amino
acid and any ligand’s O/N atoms no H-bonds were recorded under the selected starting position (SP1/SP2/SP3)
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‘‘MD-based revision of the polymeric platform advantages
for drug design’’).
Ligand-target H-bonds network from different starting
positions
Broadening the field of view to full variations of the tested
starts (S1–S3) (see Table 5), we should note that M11?3dNb
coiled SP2 conformation developed H-bonds network
similarly to the SP1 start. The both SP resulted in axial
orientation of H-bonds distribution—along the 1st helix
predominantly. An additional and detectable contribution
of contacts with 2nd helix (on the L1) in the case of SP2
was observed too. On the contrary, the SP3 starting con-
formation leaded to redistribution of the ligand-target
H-bonds network from axial priority (along 1st helix within
L1, L2 and L3) toward belting direction, involving both 1st
and 2nd a-helixes but accumulating the H-bonds within the
narrow niche of pockets of the L1 mainly.
As it followed from the Table 5 data, a moderate total
degree of the H-bonds (DHb = 4.59) between target and
ligand was registered in the case of anchor-free ligand M11,
start SP1. Similar start of anchor containing ligand
M11?3dNb resulted in the maximum H-bonding degree
(DHb = 6.44) that was noted above in respect of synergetic
intensification of H-bonding activity of the ligand carbox-
ylic chain via the pendant anchors. Start SP2 from coiled
conformation of M11?3dNb leaded to a slightly reduced
H-bonding degree (DHb = 5.66). And the same ligand
transversally unfolded conformation from the start SP3
provided the lowest degree (DHb = 4.46), probably,
because of the last start caused an occupancy of only one
niche, the L1, without contributions of L2 and L3 H-bond
capable vacancies.
Comparison of the target’s side-chains involvement in H-
bond-mediated self-stabilization and binding with ligand
From the section ‘‘H-bonds of the target’s self-organi-
zation in the coiled-coil [HR1]3 complex’’ (Tables 2, 3)
we can conclude that, having maximal potentiality to
form H-bonds trough the [HR1]3 side chains (up to 141
H-bonds), the target used for coiled-coil self-stabilization
only minor part of the degree DHb = 19.2 (i.e. 13.6 % of
the full intra-target DHb). Simultaneously, extracting the
data from ‘‘Ligand–target H-bonds formation, depending
on target’s amino acids positions and nature’’ to
‘‘Ligand-target H-bonds network from different starting
positions’’ sections (Tables 5; 6), one can find that
degree of H-bonds between the target and M11?3dNb
ligand is at even more reduced values of DHb = 4.5–6.4
(i.e. B4.5 %).
This preliminary analysis may lead to a tentative con-
clusion that ligand is able to use fewer H-bondable points
of target than the target itself contributes into the own
coiled-coil self-organization. However, it should be taken
into consideration that above we dealt with statistic data
accumulated during the full MD-simulated time (80 ns).
The network of intra-target own H-bonds was completed as
from first starting moment, while at the same starting time
the modeled ligands had no H-bonds with the target. In
contrast with the pre-filled intra-target network, the
H-bonding network between ligand and target was being
formed in processing during the all MD-simulated time, i.e.
in the dynamic development from zero starting degree
(DHb
start = 0) toward a growing degree of H-bonds. There-
fore, the statistics analysis should be completed by the
dynamics evidences.
Some dynamics aspects of total H-bonds formation
between the target and ligands
The MD simulated dynamics of H-bonds between the tar-
get and ligands, depending on the SP, is shown in Fig. 6
that is disposed in supplementary material 2.
Under the all discussed here MD-modeled systems the
original amount (QHb
start) and degree (DHb
start) of H-bonds
between the target and ligands started from zero level.
Along the simulated time these values was in progress,
achieving by final 70–80 ns the following intervals of
H-bonds instant quantity fluctuation (depending on starting
conditions): QHb ? 4–7 and DHb
70–80 ns = 6 ± 1 (M11 from
SP1); QHb ? 8–12 and DHb
70–80 ns = 9 ± 2 (M11?3dNb from
SP1); QHb ? 7–11 and DHb
70–80 ns = 9 ± 2 (M11?3dNb from
Table 6 Target–ligand
H-bonds degree distribution,
depending on the target’s amino
acid positioning in heptad repeat
motifs of a-helixes
Ligand-Start\heptad position a b c d e f g
M11 -SP1 0 0.98 0.43 0 0.004 2.41 0.77
M11?3dNb -SP1 0 1.98 0.25 0 0.004 2.87 1.34
-SP2 0 0.51 1.06 0 0.75 1.47 1.90
-SP3 0 2.00 0.87 0 0.18 0.51 1.91
Total degree of H-bonds 0 5.47 2.61 0 0.94 7.24 5.92
Total probability (%) 0 24.7 11.7 0 4.3 32.7 26.7
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SP2), and QHb ? 4–8 and DHb
70–80 ns = 7 ± 2 (M11?3dNb
from SP3).
The anchor-containing ligand M11?3dNb manifested the
higher potency in comparison with the anchor-free pre-
cursor M11 (Fig. 6 in supplementary material 2). Among
the MD-tried starts of the M11?3dNb the best H-bonding
was registered from the SP1. The SP2 provided less
dynamically active H-bonding, and SP3 demonstrated
rather not very fast (but most uneven) temp of H-bonds
formation with moderate level (like to the M11 from the
SP1 start).
Generally, the discussed order of H-bonds dynamics is
in good agreement with mentioned statistics data. How-
ever, taken into account the dynamic-probable prognosis
to further growth of the H-bonding beyond the applied
limit of MD-simulated time (80 ns), we can state a very
considerable potency of the ligands to develop H-bonds
network with the viral target. Therefore, from the
dynamics point of view, the statistics-based pre-conclu-
sion can be corrected toward more multiple (and there-
fore, the more potent) H-bonding between ligand and
target. It is right especially for the H-bonds development
by anchor-equipped M11?3dNb up to levels comparable
with the H-bonds degree used by the target for the coiled-
coil self-assembly.
Dynamics and statistic of energetic contributions
in the ligand–target binding
Besides the above considered statistics and dynamics data,
even more interesting aspect (undetectable via docking) is
evolution of energies of the various contacts in dynamics.
The ligands–target binding energy nature and a compara-
tive role of Anc and BU components in cooperative
interaction with target become more evident from analysis
of their contributions to the energy of the target binding.
Analyzing this aspect, we focused on the M11?3dNb, as
model of polymers I sub-type most relevant in the HIV-1
inhibition.
Partial contributions of various kinds of energy to total
binding energy
The MD-simulated development of DGBind and their filling
by the partial contributions of van der Waals (EvdW),
Coulomb (EQ), and solvation (GSol = Gpolar ? Gnonpolar)
forces is demonstrated in Fig. 7 disposed in supplementary
material 3.
The most significant minimization of the DGBind was
promoted via the Coulomb forces EQ. This result is in good
agreement with the chemical nature of the modeled objects
as the mutually-attracted carriers of opposite charges. The
target represents the cationic domains [HR1]3 of gp41
biopolymers, while the ligand’s backbone is unlikely
charged (anionic) polycarboxylic acid.
The Coulomb forces could be dominant part of the
DGBind if the interactions between the target and ligand
occurred in vacuum. However, for modeling a physiolog-
ical condition, a polar solvent (water with a presence of
Na?, see experimental part) should be taken into account
too. The electrostatic-relevant polar component Gpolar of
solvation energy contributed to enhancing the DGBind, i.e.,
toward dissociation—against the Coulomb binding. And
summation of EQ ? Gpolar resulted in moderate increasing
the DGBind (up to 50 kcal/mol) more preferable for
unbinding. Therefore, the MD-based estimation of the
Coulomb/electrostatic contributions only leaded to an
expectance of rather dissociation than binding between the
modeled target and ligand.
The nonpolar part of solvation energy Gnonpolar provided
the slightest effect on the level of B |-10| kcal/mol, mod-
ulating the DGBind to a very little degree.
The main resulting contribution to DGBind was filled by
the van der Waals forces. The EvdW minimizing to interval
from -50 to -80 kcal/mol was achieved by an orientation
of ligand contacts along the L1–L2–L3 zones of a-helix
(SP1 and SP2 starts). The minimal EvdW (-100 kcal/mol)
was observed from the SP3 start, which directed interac-
tions of ligand toward L1 pockets (the largest-deepest
cavities of the target). But this contribution of EvdW for
binding under the SP3 conditions was compensated by the
high counter-contribution of EQ ? Gpolar to dissociation at
the same start. It resulted in comparable values of the
summarized DGBind for the all tested starts of M11?3dNb. In
the long term, the resultant DGBind evolved as a function of
starting conditions from zero level to the following values
(kcal/mol, statistically averaged for 70–80 ns interval):
-63.0 ± 9.7 (SP1), -59.1 ± 12.5 (SP2) and -61.8 ± 14.5
(SP3).
However, such, in principle useful, consideration given
too generalized information without any special analysis of
genesis and balance of these energies contributed by dif-
ferent components of the ligand molecular structure,
notably, the anionic backbone and the pendant anchors.
Energetic contributions of polymeric chain ([BU]11)
and anchors (Anc1–3)
Before the declared analysis we should note some differ-
ences between the polymeric chain backbone and the
pendant anchors in relation to their chemical nature and
potentiality: (1) the chain is electrostatic (anionic) active
part, while the anchors possess no charged atoms in prac-
tice; (2) the polymeric chain is the major part of the ligand
molecule, containing fourfold more amount of atoms than
the three anchors taken together; (3) the backbone’s units,
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back-to-back linked into linear polymeric chain, are very
limited to be contactable with target independently on the
chain sequence and configuration, while the every single
anchor is linked to the backbone through flexible bridge
(–NH–CH2–), possessing more freedom for a mobility in
the contacts. Based on these peculiarities of molecular
organization we could expect: (1) dominant contribution to
Coulomb and polar solvation interactions by the [BU]11
component, but not by the anchors; (2) a contribution to
van der Waals interactions by the [BU]11 approximately 4
time higher than one by the anchors; (3) more evident
dynamic mobility of anchors in contacts with target, as
compare with mobility of polymeric chain.
All these prognoses met with experimental confirma-
tions by the MD-simulated results (Fig. 7 - in supplemen-
tary material 3, and Table 7).
Contributions to EQ and Gpolar The strong and dominant
role of anionic backbone in Coulomb interactions (as well
as in polar part of solvation energy) appeared evidently: the
averaged (within 70–80 ns) contributions with amplitude
up to 1,144 kcal/mol by the [BU]11 against B200 kcal/mol
by the anchors (Table 7).
Contributions to EvdW Major part of the van der Waals
forces energy was generated also due to the [BU]11 con-
tribution (38–60 kcal/mol, averaged amplitude for
70–80 ns). But the anchors contributed more considerable
(17–31 kcal/mol) than it could be expected from the 1:4
proportion of atoms amount in the Anc1–3 and the [BU]11
components, respectively. The observed proportion *1:2
(enriched by the anchors’ contribution) can be explained
exactly through the above assumed enhanced contactable
mobility of pendant anchors in contrast with the [BU]11
chain. If the chain backbone is the less mobile construction
it has require more long time for adaptation on the target
toward the binding energy sub-minimum than the time of
anchors’ adaptation. In Fig. 7 (supplementary material 3)
we can see that is really so.
A comparison of M11 and M11?3dNb in interactions with the
same target at the same start (S1) It given the valuable
information: how a presence/absence of the pendant
anchors did alter the energetic contributions to binding the
target? This comparison of two different ligand molecules
was a light additional to the estimation of comparable
contributions of anchors and [BU]11 within one molecule,
the M11?3dNb only. It was revealed that the three anchors
(in M11?3dNb against anchor-free M11) altered amplitudes
of energies considerably, as the following (Table 7):
203 % (-EQ), 196 % (Gpolar), 128 % (-Gnonpolar), 126 %
(-EvdW) and 214 % (-DGbind).
In contrast with the noted intramolecular (M11?3dNb)
proportion of partial contributions to EvdW by the anchors
and [BU]11, as 1:2, a comparison of the two different
molecules (M11?3dNb and M11) indicated the decreased
proportion (Table 7): (55.8–44.2) : 44.2 = *1:4. The last
proportion was exactly equal to the expected one in relation
to ratio of atoms in anchors and atoms in [BU]11 chain.
Therefore, the addition of anchors’ atoms (from M11
toward M11?3dNb molecules) increased the ligand ability to
interact with target via van der Waals forces proportionally
to the growth of atoms amount. But resulted entire mole-
cule M11?3dNb realized these interactions via the ‘‘leader-
Table 7 Energetic contributions (kcal/mol) of polymeric chain ([BU]11) and anchors (Anc1–3) to binding (negative values) or dissociation
(positive values) in interactions between M11/M11?3dNb and [HR1]3
Ligand Ligand’s component Start DGBind= EvdW ?Gnonpolar ?Gpolar ?EQ
M11 [BU]11 SP1 ;-29.4 ± 9.2 ;-44.2 ± 4.8 ;-5.3 ± 0.3 :?585.0 ± 119 ;-565.0 ± 122
M11?3dNb ;-56.8 ± 5.9 ;-38.4 ± 5.0 ;-5.6 ± 0.4 :?958.6 ± 130 ;-971.4 ± 131
SP2 ;-41.7 ± 7.3 ;-47.2 ± 6.1 ;-6.2 ± 0.5 :?1,098.8 ± 133 ;-1,087.0 ± 134
SP3 ;-46.5 ± 8.1 ;-60.2 ± 5.5 ;-6.7 ± 0.4 :?631.3 ± 115 ;-610.9 ± 119
M11 No Anc SP1 0 0 0 0 0
M11?3dNb 3 Anc ;-6.2 ± 2.1 ;-17.4 ± 2.8 ;-1.2 ± 0.2 :?185.5 ± 27.1 :-173.1 ± 27.6
SP2 ;-17.5 ± 2.8 ;-22.7 ± 2.5 ;-1.7 ± 0.1 :?11.5 ± 7.8 :-4.6 ± 7.9
SP3 ;-15.3 ± 3.0 ;-30.5 ± 2.7 ;-2.1 ± 0.1 :?198.3 ± 25.6 :-181.0 ± 25.4
M11 Complete molecule SP1 ;-29.4 ± 9.2 ;-44.2 ± 4.8 ;-5.3 ± 0.3 :?585.0 ± 119 ;-565.0 ± 122
M11?3dNb ;-63.0 ± 9.7 ;-55.8 ± 5.3 ;-6.8 ± 0.3 :?1,144.0 ± 131 ;-1,144.4 ± 134
SP2 ;-59.1 ± 12.5 ;-69.9 ± 6.7 ;-7.9 ± 0.5 :?1,110.2 ± 133 ;-1,091.6 ± 135
SP3 ;-61.8 ± 14.5 ;-90.7 ± 6.8 ;-8.8 ± 0.4 :?829.6 ± 118 ;-792.0 ± 122
Notes The markers ; or : indicate tendencies to alter energy from starting zero level toward decrease (factor for binding) or growth of energy
(factor for dissociation), respectively; and on the right the respective negative or positive amplitudes of energy values (kcal/mol, averaged for the
70–80 ns intervals of the MD simulated time) are represented
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enhanced’’ contribution of anchors. This result agrees also
with the conclusion about more active mobility of just
anchors in contacts with the target.
Moreover, it was interesting to find that the nonpolar
anchors twice as much intensified both Coulomb energy
and electrostatic term of solvation energy. This finding is
another, very evident, confirmation of highly active role of
the pendant anchors in interactions with the target. The
involvement of anchors stabilize simultaneously a con-
nection of poly(acid) chain with the same target. And this
anchor-induced stabilization results in significant mini-
mizing the -EQ. Apparently, being independent on elec-
trostatic-inert anchors directly, the polar interaction
depends on intensity of [BU]11—target contacts, which are
accelerated and amplified by the anchors, see sections
‘‘Role of the ligands’ anionic chain ([BU]11) and hydro-
phobic pendant anchors (Anc1–3)’’ and ‘‘Influence of
ligand’s anchors on the ligand-target H-bonds capacity’’.
Dynamic differences in the energies filling by the [BU]11
and Anc1–3 contributions As it followed from the data in
Fig. 7 (supplementary material 3), the Anc(s) linked
through the flexible bridges to backbone were distinctly
more mobile (than BU) agents for initial contacts with the
targets. Their contributions to -EvdW energy of binding
with the target achieved the minimum during very short
time (Tmin
A B 5–10 ns), while the same for the [–BU–]11
required longer period of time (Tmin
B C 20 ns) (Fig. 5).
Like the EvdW, the full DGBind reproduced this difference:
the partial contribution of anchors was filled more rapidly
than the chain backbone contribution. Analogically, within
the MD snapshots-based conformations analysis the
anchors were ahead of time in contacts with target, while
the backbone was late (for example, Fig. 4). Moreover, the
dynamic behavior of the [BU]11 in process of both H-bonds
formation and the partial energies filling, allowed to sup-
pose that these processes didn’t achieve a completeness by
the final time point of the MD-simulation (80 ns), keeping
a potentiality for probable growth beyond the simulated
time.
Comparison of the binding energy, estimated via the MD
and docking Both MD- and docking-based estimations of
binding energy between the anchors containing anionic
polymers (modeled via M11?3dNb) and the viral target
[HR1]3 resulted in values adequate to provide a powerful
binding the viral target at the physiological temperatures.
But the docking-estimated binding (Fig. 3) were stronger
than MD-simulated ones. It was relevant result so long as
the docking procedure modeled the energetically mini-
mized conformations, while the MD simulated a dynami-
cally developing process toward these minimums.
Additionally, the MD taken into account destabilizing
effects of Brownian motion as well. But the used time of
MD simulation could be too short to achieve the best (with
minimal -DGBind) conformations predicted via docking. It
can be noted that the simulated time, the 80 ns, is
approximately 1010-folds shorter than a full time required
for HIV-1 virions to complete the fusion step of entry into
cells, estimated within about 15 min [42]. MD simulation
of so long time needs too prolonged computational time
quite beyond the currently available resources of MD.
However, even the used 80 ns simulation by MD
resulted in sufficiently great values of -DGBind. And the
conformations generated via MD confirmed generally the
main binding sites and modes, predicted via the docking.
MD-based revision of the polymeric platform
advantages for drug design
A great role of polymeric compounds as a basis for tradi-
tional small molecule drugs improvement through poly-
mer-coupled drug-delivery/release strategies is well-known
[43]. Keeping this aspect without any additional consid-
eration, in conclusion of the current paper we would like
focus on fundamental differences between small and
polymeric molecules in own potentialities for a drug
design. This problem is most needed in view for feasible
advancement from limitations toward development of
therapeutic effectiveness, and from predisposition toward
prevention of a drug resistance.
Size adequacy of therapeutic ligand to the biological
targets (the nano-competent drugs)
One of the fundamental limitations of small molecules
effectiveness, as target-blocking therapeutic agents, is the
size inadequacy between such molecules (small ligands)
and the targets. A majority of the biomedical relevant
targets represent biopolymeric macromolecules (proteins,
nucleic acids, etc.) self-assembled in nano-complexes. For
example, the considered in this work protein-type viral
target [HR1]3 is a typical nano-scale (2.5 9 5.1 nm)
object.
Apparently, no any small molecule can be fully effective
blocker of same target, in principle, because the small
ligand can connect with only small part of this target, but
can’t cover main/full binding vacancies on the surface of
macromolecular target. Therefore, the size inadequacy
becomes an objective barrier of the modern drugs effi-
ciency development, if the drugs are small molecules
designed specifically for the blockage-of-target therapy.
Exactly this is the cause of slight or only moderate
efficiency of great number of small molecules screened for
the HIV-1 entry inhibition through mechanisms of binding
the gp41-related mediators of fusion. No significant anti-
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HIV effects were found in our previous investigations [3–
7] and other researchers works [44, 45] among small
molecule-type precursors, or analogous of the modeled
polymers of formula I. Particularly, the small molecules,
chemically related to the cage alicyclic pendant anchors,
were anti-HIV ineffective [3–7, 45]. Although many
among such compounds (amantadine, rimantadine, deiti-
forinum etc.) are well-known inhibitors of influenza type A
viruses, this activity we interpret as a result of these small
ligands penetration into the viral proteins M2 complex (the
intra-target intervention) [47], but not due to any external
binding the target, that is impossible in fact of the dis-
cussed here nano-scale inadequacy.
In contrast with the small molecules, the pendant
anchors containing polymers of formula I (Scheme 1) are
high selective and efficient inhibitors of the HIV-1 entry
in vitro [3–7]. In silico modeling via our suggested step-by-
step docking algorithm [9, 16] for interactions between
synthetic and biological polymers (by example of the
polymers I and the viral [HR1]3 target) explains the in vitro
recorded data with good correlation. The docking pre-study
led us to clear understanding the role of the ligand–target
size adequacy in concrete terms of geometrical parameters,
required to strong binding this target axially or by belting
via the polymeric compounds in contrast with small mol-
ecules, modeled as fragments of these compounds (Fig. 3).
In this paper the docking predicted size of the polymeric
ligands needed for axial (C5.1 nm) and belting (C8 nm)
binding the [HR1]3 (see in Fig. 3), was verified in the MD
procedure by examples of the 11-meric chain-based models
of polymeric ligands (the M11 and M11?3dNb). The MD
simulation, generally confirming the docking prediction,
demonstrated additionally a dynamic evolution of the
forecasted intervention of synthetic polymers I in interac-
tions with the viral target. This intervention was modeled
from various SP and considered in relation with synergic
role of mutual cooperation of anionic polymeric chain and
pendant anchors, where the both BU monomers and indi-
vidual anchors represented, separately, the small molecules
themselves ineffective against HIV.
Therefore, the following postulate can be accepted: the
geometric scale of a ligand (drug) comparable with the
molecular scale of a target is the precondition crucially
needed for a maximally realizable efficiency of binding this
target (through an optimization of the ligand’s chemical
structure within this size adequacy).
From separate small molecules toward synergic-
cooperated polyligands (the multipoint-binding drugs)
So the small molecules are very limited sours for a drug
design of agents for blocking the (bio)macromolecules
((bio)nano-objects), in principle. On the other hand, as we
asserted before [8, 47], the same small molecules can be
mostly useful agents as antimetabolites (in competition
with natural low-molecular mass metabolites) or as
antagonists/inhibitors of active centers of bio-receptors or
enzymes, if these centers are precisely adequate to the
small molecules geometry. On the contrary, a full inhibi-
tion of such centers simultaneously with relevant allosteric
co-factors of entire macromolecule (or macromolecular
complex) needs just the size-comparable polymeric agents
preferable. And exactly the macromolecular poly-ligands
can be the best therapeutic tools to cover main surface of
target, if the target should be efficiently blocked by means
of binding. In this relation, the macromolecular approach to
drug design is a strategic priority of our research group [7–
10, 47].
Below we would like demonstrate an appropriateness of
this proposition by detailed examples from the docking and
MD co-investigation of the considered molecular objects.
Mutual cooperation of the modeled ligand’s components in
binding the target As followed from the docking pre-
study [9, 16, 48] (Fig. 2), the small-size precursors of
polymers I,10 modeled as a single small molecule, were
capable of cowering simultaneously only a narrow local
part of full contactable surface of the viral target (Fig. 2,
step 1). And the best binding energy (simulated via dock-
ing) was observed in contacts within one from deepest
pockets at the 1st level (L1) pockets triplet of the target.
However, any from among such contacts between the
‘‘small ligand’’ and the ‘‘big target’’ achieved binding
energy no more than |-DGBind| B 20 kcal/mol (ibid). This
is too slight energy to support a stable binding under
physiological temperatures (because of Brownian move-
ment). Thus, the computer-aided modeling cleared the
cause of the mentioned experimental facts of the anti-HIV
inefficiency of the real small molecules, evaluated in vitro
[3–10].
A subsequent modeling the (olygo/poly)meric ligands,
using both docking (Fig. 2, steps 2 and 3) and MD tech-
niques, evidently revealed a significant growth of achiev-
able values of |-DGBind| [ 50 kcal/mol (Fig. 3, Fig. 7 in
supplementary material 3, and Table 7). This is quite
enough energy to provide the very stable binding (and the
anti-HIV protection in vitro observed). Certainly, the
binding power growth should be logical result from the size
escalation of a ligand molecule (especially due to the EvdW
contribution), but if the ligand’s sub-structural units are in
cooperative synergism (or additivity), and not in crucial
antagonism (competition) within interactions between the
ligand and target.
10 The monomeric units of polymeric chain or alicycles related to the
pendant anchors.
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The main principles for a synergistic macromolecular
drug design were formulated and studied, particularly, in
our previous works [7–9, 16, 47–50], and now they are
cleared and developed on the platform of the current
computer-aided modeling.
As one could see above, the antiviral active polymeric
ligands of series I were designed as a cooperation of many
small anionic units BU toward linear and flexible enough
chains [BU]n followed by grafting the special pendant
anchors at certain distances along these chains.
The poly(carboxylic acid) chain nature was chosen in
view of nature of the viral protein target: (1) to be elec-
trostatic-attractive to the target through interactions
between the negatively ionizable carboxylic groups and
counter-ionizable groups of side chains of Arg/Lys/His
residues of target, as well as (2) to be able to form multiple
H-bonds with the target due to multi-repeated along the
ligand’s chain H-bond-active oxygen atoms (Table 4, for
instance). The 11-meric length of the polymeric chain for
the MD testing was selected on the base of the docking
prediction (Fig. 3): (1) to be able to cover more than full
length ([5.2 nm) of a single a-helix of [HR1]3, using all
three levels of the target’s cavities/pockets (the L1, L2 and
L3), as well as (2) to be capable of belting the target.
The pendant alicyclic anchors chemical nature was
originally (at step of design for synthesis) selected: (1) in
contrast with nature of the polyanionic chain to be not rival
(in respect to electrostatic or hydrogen bonds), but to be
complementing component oriented toward hydrophobic
sites of targets; and (2) in view of a background of ada-
mantane and norbornane-related alicycles as synthetic core
for antiviral compounds (well-known mostly in anti-influ-
enza therapy [52], but not in anti-HIV treatment). Among
the possible alicyclic structures the dNb species and their
dislocation in side positions of polyanionic chain was
selected by in vitro screening [3–10] in search for most
anti-HIV-1 active synthetic polymers of the series I fol-
lowed by the docking-based analysis [9, 16] (Fig. 3, for
example).
Resuming the discussed in this article MD simulation,
we accumulate the following relevant manifestations of the
ligand’s components synergetic cooperation in relation to
an amplification of the binding with target.
1. The cooperation of monomer units BUs toward
11-meric chain (the [BU]11) leaded to:
• 11-folds multiplication of the ligand capacity of
multi-point binding with target;
• expanse of geometrical ability to cower simulta-
neously not single cavity/pocket but all three levels
of cavities/pockets along full length of the target’s
a-helix, or to belt the target;
• centipede-like movement of poly(carboxylic acid)-
chain on the target surface (section ‘‘A centipede-
like movement of poly(carboxylic acid)chain on
the target surface’’);
• growth of amplitude of energetic contribution to
total binding energy up to |-DGBind| = 50–75 -
kcal/mol, and, probably, more (section ‘‘Energetic
contributions of polymeric chain ([BU]11) and
anchors (Anc1–3)’’)
2. The grafting of three pendant anchors of dNb-type to
the [BU]11 chain resulted in:
• twice more intensive contacts between ligand and
target by virtue of the anchors-induced 14 %
growth of amount of BUs-target contacts plus
93 % increase due to additional anchors (them-
selves)-target contacts (section ‘‘Role of the
ligands’ anionic chain ([BU]11) and hydrophobic
pendant anchors (Anc1–3)’’);
• half as more intensive H-bonding (section ‘‘Influ-
ence of ligand’s anchors on the ligand-target
H-bonds capacity’’);
• assistance for [BU]11 to be more contactable with
target via facilitating an involvement in centipede-
like movement on the target’s surface (section
‘‘Role of the ligands’ anionic chain ([BU]11) and
hydrophobic pendant anchors (Anc1-3)’’);
• a considerable additional contribution of anchors
into binding energy, especially, through the van der
Waals forces (section ‘‘Energetic contributions of
polymeric chain ([BU]11) and anchors (Anc1–3)’’);
and, at last,
• the accelerating effect of anchors on BU species
involvement into synergetic contacts with target in
dynamics.
Really, the presence of anchors provided very relevant
(but undetectable via docking) effect on BU species
involvement into synergetic contacts with target in dynam-
ics. The anchors demonstrated a leading mobility as a time
advanced agents for initial binding with target, followed by
the next anchor-induced contacts with target of chain units
linked to anchors (by bridges). Then other BU step-by-step
are involved (through the back-to-back co-linkage of the BU
monomers into the polymeric chain). The capability of
anchors to be quickly contacting initiators in interactions
with target was detected in focus on both mechanical and
energetic manifestations (sections ‘‘Dynamic evolution of
distances between ligand’s and target’s substructures’’ and
‘‘Energetic contributions of polymeric chain ([BU]11) and
anchors (Anc1–3)’’, respectively).
In fact, via the MD simulation, we revealed the essential
role of anchors as factors of acceleration and amplification
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of the binding between the polymeric molecules and the
viral target. This finding opens an evident explanation of
the early reported [3–10] experimental fact of enhanced
anti-HIV activity in vitro of the anchor containing poly-
mers in comparison with anchor-free precursors (or small
molecules related to single anchor or BU).
Thus, the Anc(s), being less energetically powerful than
full polymeric backbone (section ‘‘From separate small
molecules toward synergic-cooperated polyligands (the
multipoint-binding drugs)’’), nevertheless, play very
important role initiating first contacts with the target, and
promoting subsequent involvement of BU(s) in the same
interactions.
On the other part, multiple BU(s) stabilization on the
target surface leaded to more stable anchors—target con-
tacts too. As a result, even those local contacts, which were
estimated as week—unstable (in the docking of small
molecule models of single BU/Anc species) [9, 16], in the
MD were re-qualified as quite stable [18] in virtue of the
polymeric organization, that cooperate such species toge-
ther. A local lost of contacts of any single Anc/BU with the
target were reversibly restored in dynamics due to other
(neighbouring) BU(s)/Anc(s) connections with the same
target.
This situation can be illustrated in visible details via step-
by-step analysis of the MD simulated snapshots in dynamics
(of 0.1 ns intervals). As soon as the full sets of 800 snapshots
(for every start) are too extensive data base, we represent
some brief description only (see supplementary material 4).
It demonstrates evidently that the polymeric coupling of
small molecule units leads to a cooperation which is very
relevant for behavior and functionality of the units in the
‘‘polymeric team’’. Under the cooperation both antagonistic
and additive/synergic effects in local and summarized
interactions of components of polymeric ligands with targets
can be fulfilled, depending on molecular design. Basing on
the considered results of MD analysis we should state that
the selected molecular structure of M11?3dNb is enough
optimal design to promote rather the synergism than
antagonism in binding the tested viral target.
In general case, if the molecular architecture is suc-
cessful, the cooperative potency of polymerized molecular
systems becomes a crucial fundamental advantage of
polymeric compounds in comparison with small molecules.
And, therefore, this fundamentals cannot be excludes from
theory and practice of novel materials development,
including the drug design.
Drug efficiency and drug resistance
The cooperatively accelerated and amplified ability of
M11?3dNb to bind the HIV-1 fusion mediator [HR1]3 (in the
represented MD simulation) supplies clear explanation of
high efficiency of compounds I (Scheme 1 where
X = active anchors in amount of 6–8 % among all X) as
inhibitors of the virus entry into cells, and, therefore, as a
drug-capable preventive agents for anti-HIV/AIDS therapy.
But the preventive/therapeutic efficiency is only one side
of a global problem in area of drug design. The other side
of the matter (that becomes more and more dangerous
barrier for antimicrobial drugs development) is a drug
resistance. No any drug design based on small molecules
platform, exclusively, can ensure a cardinal solution of this
problem.
Why is it? It is so because even a combination of small
molecules is not their ‘‘covalently-coherent cooperation’’
in contacts with a macromolecular target. The covalently
unbound (non-cooperated) small particles act indepen-
dently (at absence of any coordinating forces). And
Brownian movement, chaotically dispersing them, does not
allow a combination of small molecules to act simulta-
neously against a target. But if the small species are
covalently pre-cooperated together in some polymeric
molecule they become capable of mutually-synchronized
intervention in contact with other macromolecule (a tar-
get).11 Without this covalent co-linkage (‘‘the polymer-
specifically determined cooperation’’) any abilities of small
molecule drugs to full inhibition of such targets are
strongly limited by the size-inadequacy of single small
molecule (section ‘‘Size adequacy of therapeutic ligand to
the biological targets (the nano-competent drugs)’’) and by
non-coordination of any different small molecule drugs
mechanically combined for a therapy.
That’s why even modern combined antiretroviral ther-
apy (included in HAART strategy through anti-HIV/AIDS
‘‘cocktails’’) is not fully effective and very liable to drug
resistance, provoking more and more dramatic multi-drug
resistance in long-term therapy [1, 53].
In spite of a drug resistance itself is caused by mutations
(of viruses, for instance), the yield of any drug resistant
mutants is crucially limited by efficiency of the drug to block
reproduction of the mutable microorganisms (viruses). A
probability of the drug resistant mutant genesis depends of
scale of part of the target that is blocked by the drug. If some
small molecule drug controls only adequately small part of
polypeptide sequence of target, just the one (point) mutation
can be enough to generate resistance against such drug. And
probability of the single mutation is rather high.
In contrast with small molecules, antibodies (the natural
polymeric ligands for selective binding) interfere with more
long sequences (antigen determinants) of targets. Quite more
11 Just as a combination of small amino acids is not protein, the
biopolymer covalently cooperated a sequence of many amino acid
residues, i.e. cooperatively accumulated their partial structures and
functionalities.
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large part (or even full macromolecule) of target can be
covered by binding through the cooperative manner, realiz-
able via specially designed synthetic polymers, similar to the
polymers of series I [8]. To become free from drug control of
such polymeric inhibitors, not one-point but many-points
mutations are needed simultaneously. A probability of the
drug resistance against multipoint-binding drug a priory
should be many folds less, as the product of probabilities of
point mutations along all sequence of target.12
In focus on the tried target [HR1]3, the mediator of HIV-
1 entry (fusion step), we should accentuate the following
findings: (1) any small molecule ligand is able to bind
adequately small site of the target, only at either L1, or L2,
or L3, but not two or several sites simultaneously (pre-
studied via docking); (2) polymeric ligands based on chain
backbone, length of which is comparable with (or more
than) nano-dimensions of the target, are capable of cov-
ering full-length a-helixes, the L1, L2 and L3 (36 amino
acids sequence) simultaneously due to the discussed here
cooperation of BU species and pendant anchors.
This cooperation for multipoint binding the viral target
by the polymeric (type I) ligands is detectable in space (in
the geometric and energy terms) via both docking and MD
modeling, while the same cooperation in-time (in dynamic
evolution of reversible contacts toward binding network) is
undetectable via docking. It becomes clearly visible in MD.
Therefore, taken together the docking and MD data, the
polymeric type I inhibitors of HIV infection can be
expected to be capable of a significant suppression of yield
of drug resistant viral mutants. In theory, this is estimated
effect of the cooperative (multilevel) blocking the more
extended areas (and mutagenesis risks) of viral target(s).
In fact, this finding (pre-formulated previously [7, 8], tried
by the docking [9, 16] and verified via the MD) is in a good
agreement with the experimental result of in vitro evaluation
of the polymeric sample of series I (where Anc = Ad),
closely-related to the M11?3dNb. No significant resistance of
HIV-1 mutants to this anti-HIV-1 active compound was
achieved during long-term (40 days) experiment [7].
Conclusions
1. Complementary co-application of the docking and MD
is the very productive and improvable approach to in-
depth modeling and investigation of interactions
between synthetic and biological polymers. The step-
by-step algorithm of docking [16] allows to find mainly
probable sites and modes of binding the bio-polymeric
target by synthetic polymer ligands and to estimate the
binding energy minimums. Besides, it gives useful ori-
entation for planning of following MD experiment
(options for starting conformations, e.g.). The docking-
based results and extrapolations can be verified and
developed appreciably by the MD via simulation of
larger scale molecules of polymeric ligands, taking into
account a conformational flexibility of both synthetic
(‘‘ligand’’) and biologic (‘‘target’’) polymers, as well as
evolution of their interactions in time.
2. By the example of HIV-1 envelope glycoprotein gp41
nano-complex of [HR1]3, the virus fusion mediator, as
a target, and 11-meric polyelectrolyte chain contained
three pendant anchors of dinorbornene (M11?3dNb, the
representative model of highly active inhibitor of HIV-
1 entry), and its anchor-free precursor (M11, the model
of weakly active anti-HIV inhibitor), the both as
ligands, the following findings were revealed.
2.1 The target in presence of the tested ligands
under physiologically relevant temperature
maintained generally own self-organization as
the coiled-coil three a-helixes nano-complex
(5.1 9 2.5 nm). In Brownian fluctuations it kept
the classical order of self-formation (due to
H-bonds between i ? 4 NH and i O=C pairs of
polypeptide backbone) of a-helixes, which then
self-assembled in the three-helix coiled-coil
complex [HR1]3, using the side chains of amino
acid residues in a and d positions of heptad
repeat motifs.
2.2 The amino acid residues in b, c, e, f, and
g positions of heptad repeat motifs (especially in
respect of H-bond and/or hydrophobic active
side chains), unused in the intra-target self-
organization, were found to be accessible and
active points for binding with the external
polymeric ligands.
2.3 Clarifying the target’s binding capability, the
MD verified (from variable starting conforma-
tions) the pre-identified via docking main sites
and modes of a probable binding between the
target and the ligands. In fact, the MD con-
firmed both the general binding locus at first
level (L1) of target’s pockets and additional
sites at second (L2) and third (L3) levels of
cavities that together provided a network of
active vacancies for an occupation by ligands.
The MD corroborate also the docking-predicted
probability of the ligands attachment by the
modes for axial covering (the all levels L1–L2–
L3 along a-helix of target) or for belting around
the level(s).
12 For independent events (in the considered case, the mutations), the
probability of the chance of all of two or more events occurring
(intersection of the events) is the product of the probabilities.
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2.4 Verifying the docking (step 3) extrapolation
toward ligands with enough long-length poly-
meric chains, the MD demonstrated the principle
of size-adequacy between target and ligand to
provide a full-scale occupation-binding of the
target. Particularly, the docking-predicted ability
to cover both lengthwise and belting dimensions
of the nano-target by the 11-meric chains of M11/
M11?3dNb models was observed in MD simula-
tion. Just the polymeric chain size expands a
geometrical ability to cover simultaneously not
single site/cavity/pocket but all three levels of
cavities/pockets along full length of the target or
to belt the target. Taken together, the docking and
MD results demonstrate the principle of size-
adequacy as a fundamental advantage of poly-
meric compound (against small molecules) to be
essentially more efficient agents (ligands) in drug
design for a binding-type arrest of biopolymer
(nano)targets.
2.5 The diversity, multiplicity and synergism of
contacts with a target, which can be realized
through polymeric-type cooperation13 is
another fundamental advantage of the polymeric
ligands for a drug design. In this relation the
MD generated new data in addition to the
docking pre-studied effects of possible mutual
synergism/additivity/antagonism between vari-
ous sub-structural units (components) of a
ligand in binding with target, depending on the
ligands’ molecule design. The MD simulation of
the most anti-HIV active polymeric sample by
the M11?3dNb model, for this concrete case,
demonstrated evidently an expressive trend to
priority of the target-binding synergism between
their sub-molecular components: the anionic
monomer units (BU) co-linked in the quite
flexible polymeric chain (the backbone) and
pendant anchors grafted by bridges to this chain
at the optimal distances.
The polymer-cooperated accumulation of the
target-binding potential was registered through
at least following manifestations: (1) 11 folds
multiplication of the ligand’s capacity of many-
point binding with target due to the 11-meric
repeating the BU units along the polymeric chain
itself; (2) ability of the poly(carboxylic acid)-
chain to move on the target surface via centi-
pede-like manner; (3) crucial role of the pendant
anchors as additive and/or synergetic factor for
acceleration, amplification and stabilization of
multipoint binding the target. The only three
anchors (grafted to M11?3dNb in contrast with
M11) resulted in twice more intensive contacts
between ligand and target, half as greater
H-bonding, and considerable additional contri-
bution into binding energy. Moreover, the sig-
nificant accelerating effect of the anchors on
involvement of BU species into contacts with
target and the mutual adaptation on the target
surface in dynamics were observed.
The all noted findings, taken together, give new informa-
tion very important for elucidating the molecular mecha-
nisms of the modeled inhibition of HIV-1 entry by the real
synthetic polymers [3–10], explaining causes of their
enhanced antiviral efficiency and drug resistance preven-
tion as opposed to small molecule analogues. Therefore,
the obtained knowledge is a valuable platform for the novel
drug design based on synthetic polymeric compounds in
view of discussed here fundamental advantages of poly-
mers in contrast with (and in addition to) ‘‘traditional’’
small molecule drugs.
Some unconsidered aspects of a computer-aided mod-
eling, synthesis and bio-evaluations of same and other
polymeric compounds-ligands (with variations of poly-
meric chains structure/flexibility and nature/functionality
of side anchors/branches, etc.) will be represented in our
subsequent publications.
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